DT
DNP THERAPEUTICS INC
SEC filingOther Technology · Cambridge, MA
Amount raised$470Ksold at filing
Total offering$1M$530K still open
Investors in the raise7count reported to the SEC
FiledMar 23, 2026first sale Mar 5, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Randall Craig MazzarinoExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.